77 participants
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2023-03-24
- Completion:
- 2025-01-31
Conditions
- Melanoma Metastatic
No Results Yet